BrainCure: the blue hope against a group of ultra-rare diseases

BrainCure

Researchers from the Pablo de Olavide University have patented a new method that allows them to determine which drugs combination is more effective for the treatment of NBIA disorders in each patient. This group of ultra-rare diseases affects 60 people in Spain. NBIA disorders cause neuron death through brain iron accumulation. This study, named BrainCure, […]

Continue reading